Researchers Uncover New Role for Tamoxifen in Triple-Negative Breast Cancers Roswell Park team identifies first known prognostic marker for these aggressive tumors

TNBC tumors lack 3 key receptors that existing therapies target Team led by Dr. Gokul Das focused on a different receptor, ER-beta They demonstrate that tamoxifen may be effective against many TNBC tumors. One of the mechanisms that makes so-called triple-negative breast cancer (TNBC) notoriously aggressive and

Read more